Glutamine homeostasis regulates PD-L1 level through STAT3 in pancreatic cancer

Glutamine is one of the most important metabolites and energy sources for cancer cell proliferation. However, the function of glutamine homeostasis to modulate immunotherapy by regulating immune checkpoint protein expression remains elusive. Here, we report that glutamine abundance increases the expression of the immune checkpoint protein PD-L1 through STAT3 signaling in pancreatic cancer cells. Mechanistically, STAT3 directly interacts with PD-L1 under glutamine stimulation and stabilizes PD-L1 protein by preventing it from ubiquitination and degradation. Additionally, our study suggests that PD-L1 may respond to cellular glutamine levels to regulate mTOR activation and pancreatic cancer cell proliferation. Overall, our study unveils a novel mechanism by which glutamine up-regulates PD-L1 expression to activate mTOR and promote cell proliferation, highlighting a crucial role of PD-L1 in regulating the metabolism of glutamine in pancreatic cancer.

Authors

Institutions

Publication Details

Journal
Genes & Diseases
Published
2026-02-01
DOI
https://doi.org/10.1016/j.gendis.2026.102092
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Glutamine homeostasis regulates PD-L1 level through STAT3 in pancreatic cancer

Huaitao Wang, Wuxiyar Otkur, Xiaodong Tan, Siyi Li et al.
Genes & Diseases
Cancer Immunotherapy and Biomarkers
article

Glutamine homeostasis regulates PD-L1 level through STAT3 in pancreatic cancer

Huaitao Wang, Wuxiyar Otkur, Xiaodong Tan, Siyi Li, Ting Ling, Wei Pan, Huan Qi, Yaguang Sun, Qi Zhang, Zeyu Li, Rui Li, Hai-long Piao, Jinghan Li, Tian Xia
article en

Abstract

Glutamine is one of the most important metabolites and energy sources for cancer cell proliferation. However, the function of glutamine homeostasis to modulate immunotherapy by regulating immune checkpoint protein expression remains elusive. Here, we report that glutamine abundance increases the expression of the immune checkpoint protein PD-L1 through STAT3 signaling in pancreatic cancer cells. Mechanistically, STAT3 directly interacts with PD-L1 under glutamine stimulation and stabilizes PD-L1 protein by preventing it from ubiquitination and degradation. Additionally, our study suggests that PD-L1 may respond to cellular glutamine levels to regulate mTOR activation and pancreatic cancer cell proliferation. Overall, our study unveils a novel mechanism by which glutamine up-regulates PD-L1 expression to activate mTOR and promote cell proliferation, highlighting a crucial role of PD-L1 in regulating the metabolism of glutamine in pancreatic cancer.

Genes & Diseases
Shenyang Pharmaceutical University (CN), Dalian Institute of Chemical Physics (CN), Shanxi Provincial Cancer Hospital (CN), Hainan General Hospital (CN), China Medical University (CN)
Affordable and clean energy
Openalex Percentile: Top 55%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.